San Francisco-based Hike Medical has raised $22.5 million in combined seed and Series A funding to expand a vertically integrated platform that pairs clinical software with in-house 3D-print manufacturing — betting that owning the entire chain, from smartphone scan to shipped device, is the fastest way to fix a notoriously slow corner of durable medical equipment.
The round was led by Saga Ventures — co-founded by Max Altman, who serves as the firm's managing partner — with participation from Indicator Ventures, Fifth Down Capital, RiverPark Ventures, and orthotics maker Orthofeet, alongside angel investors Sam Blond and Jerod Mayo. Hike Medical CEO Aadi Bhanti and Altman were both quoted in the announcement, though the company has not disclosed a formal valuation for the round.
What Hike Medical Actually Builds
Hike Medical sits at the intersection of clinical software and additive manufacturing. According to the company's own site, patients or clinicians capture a foot with a smartphone-based 3D scan rather than the traditional foam-box impression or plaster cast, and that scan feeds directly into Hike's clinical workflow and referral-processing software. From there, orders route to the company's manufacturing floor through a largely automated pipeline — the company frames automation, not just scale, as the core of the product.
That manufacturing floor is the part of the story that print-farm operators will find most interesting. Hike Medical says its 65,000-square-foot facility in Peoria, Illinois runs more than 600 printers around the clock, which the company describes as the largest orthotic print farm in the United States. The 3D Printing Industry report says Hike is targeting an annual capacity of more than 500,000 pairs of custom insoles — a goal, not yet a confirmed run-rate. For a category — custom orthotics and other durable medical equipment (DME) — that has historically depended on regional labs, foam-box shipping, and multi-week turnaround, that's a fundamentally different production model.
The Numbers Behind the Pitch
Two figures anchor Hike Medical's case for vertical integration. First, turnaround: the company says devices now ship in about five business days, down from what the industry has typically measured in weeks. Second, and arguably more telling for anyone who has run a print farm at scale, is the remake rate — the percentage of devices that come back because they don't fit or fail some other tolerance check. Hike says that number has dropped from roughly 1-in-15 to 1-in-400.
That's a 26x-plus improvement, and it's the kind of number that print-farm veterans will recognize as a proxy for process control rather than printer count alone. Cutting remakes at that scale generally means one of three things is happening (or, more likely, all three): the scanning-to-model pipeline has gotten dramatically better at capturing accurate patient geometry, the slicing and toolpath generation has been tuned and standardized so print-to-print variance stops being a source of fit error, and quality inspection is catching problems before shipment rather than after a patient complaint. A 65,000-square-foot facility running 600+ machines around the clock only pays off if the failure rate is low enough that idle-printer time and reprint costs don't eat the throughput gains — which is presumably why Hike is leading with that metric rather than burying it.
What It Means for Makers
For readers who run their own farms — even at a fraction of Hike's scale — this raise is a useful data point on where high-volume, application-specific 3D printing is heading commercially. A few things stand out:
Vertical integration is the moat, not the printer count. Six hundred machines is a lot of hardware, but the funding pitch isn't "we bought more printers than anyone else." It's that owning the scan, the clinical software, the slicing/print pipeline, and the fulfillment logistics end-to-end lets Hike compress a multi-week supply chain into about five business days. Anyone scaling a print operation for a specific vertical — dental, prosthetics, custom footwear, jigs and fixtures — should read the remake-rate improvement as the real signal: process discipline across the whole pipeline, not raw machine count, is what turns a print farm into a defensible business.
Smartphone scanning keeps eating specialized capture hardware. Hike's pitch depends on patients or clinicians being able to generate print-ready geometry from a phone camera rather than a dedicated 3D scanner or a physical cast. That's consistent with a broader trend in consumer and prosumer 3D printing, where photogrammetry and LiDAR-equipped phones have steadily closed the gap with purpose-built scanning rigs for applications that don't need micron-level tolerance.
Continuous-run farms remain a capital and operations story, not just a hardware one. Running 600+ printers "around the clock," as Hike describes it, implies serious investment in maintenance scheduling, material handling, farm software, and staffing — the unglamorous infrastructure that rarely shows up in a funding headline but determines whether a farm actually hits its uptime targets. Makers scaling their own multi-printer operations, even at the 10- or 50-machine level, will recognize that the hard part isn't acquiring the printers; it's keeping them fed, calibrated, and producing parts that don't come back.
Neither the 3D Printing Industry report nor Hike Medical's site discloses per-device cost, reimbursement structure, or how the company's insurance and DME billing relationships work — details that matter for anyone trying to size the addressable market this funding is chasing. Those specifics weren't part of the announcement, and Hike Medical hasn't published them separately.
Bottom Line
Hike Medical's $22.5 million round is a bet that the orthotics and DME industry — long dependent on plaster casts, regional fabrication labs, and multi-week fulfillment — is ready for the same vertically integrated, print-farm approach that has already reshaped smaller corners of custom manufacturing. The company's own numbers — a turnaround cut from industry-typical weeks down to about five business days, and a remake rate improved by more than 26x — suggest the operational playbook is working at least at Hike's current scale. Whether it holds as the company pushes toward its stated goal of 500,000-plus pairs in annual capacity — and whether competitors follow with their own print farms — is the next thing worth watching.
